A gene, ClCDA, encoding chitin deacetylase from Colletotrichum lindemuthianum, was optimized according to the codon usage bias of Pichia pastoris and synthesized in vitro by overlap extension PCR. It was secretorily expressed in P. pastoris GS115 using the constitutive expression vector pHMB905A. The expression level reached the highest with 110 mg/l culture supernatant after 72 h of methanol induction, which comprised 77.27 U/mg chitin deacetylase activity. SDS-PAGE, mass spectrometry, and deglycosylation assays demonstrated that partial recombinant protein was glycosylated with an apparent molecular mass of 33 kDa. The amino acid sequences of recombinant proteins were confirmed by mass spectrometry.
Chitin deacetylase (CDA, E.C. 3.5.1.41) is an enzyme that hydrolyses the N-acetamido groups of N-acetyl-Dglucosamine (GlcNAc) residues in chitin to produce chitosan [25] . It is one of the members of the carbohydrate esterase family 4 according to the CAZY database (http:// www.cazy.org/) [5] . CDAs have been reported to occur in several fungi, some insect species, and marine bacteria [29] . The most well-studied CDAs are those from the fungi, such as Mucor rouxii [2, 13] , Absidia coerulea [9], Aspergillus nidulans [1], Saccharomyces cerevisiae [7] , Schizosaccharomyces pombe [16] , and Colletotrichum lindemuthianum [19, 22] .
Chitosan, the hydrolysis product of chitin by CDA, has great potentials in many industrial applications, such as materials science, biomedicine, food ingredients, cosmetics, and pharmaceuticals [8] . Compared with the presently used chemical procedure, the use of CDA for the conversion of chitin to chitosan has advantages, such as easily controlled, environmentally safe, and non-degradable process, resulting in the production of novel, well-controlled chitosan polymers and oligomers [12] .
To the present, although some CDAs have been reported to be heterologously expressed in Escherichia coli [21, 23] and P. pastoris [18, 10] , the proteins yields were not high. Therefore, it limits the application of CDAs in large-scale biotechnology.
In this study, in order to obtain CDA possessing high yields for high-scale production of chitosan or deacetyl Nchitooligosaccharides, the CDA gene from C. lindemuthianum (ClCDA) was optimized based on the codon usage bias of P. pastoris and synthesized with overlap extension PCR, and the putative signal peptide was deleted from ClCDA. We described the optimal DNA sequence synthesis, recombinant strain construction, and secretory expression in P. pastoris. To our knowledge, this is the first report of a high production of CDA through gene synthesis and codon optimization.
MATERIALS AND METHODS

Reagents
Chitosan was purchased from Sigma (USA). The BCA protein assay kit was purchased from Beyotime Institute of Biotechnology (P. R. China). All other chemicals were of the highest purity commercially available.
Strains, Plasmids, and Media E. coli XL10-GOLD and P. pastoris GS115 were from Invitrogen (USA). The vector pMD18-T was from Invitrogen (USA) and pHBM905A is stored in our laboratory. Buffered glycerol-complex medium (BMGY), buffered methanol-complex medium (BMMY), and minimal dextrose medium (MD) were prepared as described in the instruction manual of the Invitrogen Pichia expression kit (USA).
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Design and Synthesis of ClCDA Gene A DNA-coding sequence, suiting the triple codon preference of P. pastoris, was modified from the CDA gene of C. lindemuthianum (GenBank Accession No. AY 633657). In order to synthesize ClCDA, 22 oligonucleotides (Table 1) were designed with the DNAWorks program (http://helixweb.nih.gov/dnaworks/) for overlap extension PCR. For designation of the oligonucleotides, several parameters should be defined. These parameters include the target genome (currently limited to P. pastoris), annealing temperature (currently limited to be within 58-62 o C), and the oligonucleotides length (currently limited to be within 48-52), and the other parameters were kept at default settings. Subsequently, the amino acid sequence of the protein was input into the "Sequence(s)" column, and then the oligonucleotides were designed. The PCR process was performed according to previous reports [4, 6] . The synthesized ClCDA fragment was cloned into pMD18-T for DNA sequencing.
Construction of Expression Plasmid for the Expression in P. pastoris GS115
The full-length ClCDA fragment was amplified with primers p-clcd-1/p-clcd-22 (Table 1) , and then digested with T4 DNA polymerase supplemented with dTTP to form overhangs compatible with the sticky ends of the pHBM905A previously digested with CpoI and NotI [28] . After this, these two fragments were ligated, and the recombinant plasmid, named pHBM-ClCDA, was confirmed by PCR and DNA sequencing. Transformation of P. pastoris GS115 and expression of the recombinant protein were carried out according to the manual of the Pichia expression kit (Invitrogen).
Yeast Transformation
The recombinant yeast expression plasmid was linearized with the restriction enzyme SalI, and then transformed into P. pastoris GS115 by electroporation (7,500 V/cm, 25 lF, 400 X; Bio-RadGene Pulser, USA). The positive His + transformants were selected on MD plate, and then confirmed by colony PCR.
Expression and Purification of Recombinant ClCDA
These positive colonies were cultured in a 1,000 ml shake flask containing 100 ml of BMGY at 28 o C for 2 days. Cells were harvested by centrifugation at 5,000 ×g for 10 min at 4 o C and recultured in 100 ml of BMMY at 25 o C for 7 days, followed by induction with 1.0% methanol every 24 h. To purify the recombinant ClCDA, cultures of the transformants were centrifuged at 15,000 ×g for 15 min at 4 o C. The cell-free supernatant was concentrated at 75% saturation of ammonium sulfate at 4 o C for overnight. The resulting precipitate was collected by centrifugation at 15,000 ×g for 15 min at 4 o C, and then dissolved in 20 mM Tris-HCl (pH 7.0). The purified ClCDA was used for biological assays.
SDS-PAGE and Protein Concentration Determination
SDS-PAGE was performed according to Laemmli [15] . After electrophoresis, proteins were stained with Coomassie Brilliant Blue R-250. The concentration of the purified ClCDA was determined using a BCA protein assay kit with bovine serum albumin as a standard.
Identification of the Recombinant Protein by Mass Spectrometry
Bands of target proteins on the SDS-PAGE gel were excised, and then identifications were carried out according to the previous report [17] . The peptides were analyzed with an Ultraflex II MALDI-TOF/ TOF mass spectrometer. The result of the peptide mass fingerprint (PMF) was processed with Biotools software and searched against the National Center for Biotechnology Information (NCBI) database using the Mascot search engine (http://www.matrixscience.com).
Deglycosylation of ClCDA
Deglycosylation of recombinant protein was performed according to instructions of the manufacturer (New England, Biolabs). The protein was denatured at 100 o C for 10 min, and then incubated with Endoglycosidase H (Endo H) at 37 o C.
Activity Determination of the Recombinant ClCDA ClCDA activity was assayed by the method reported by Win and Stevens [27] . Enzymatic activity was measured at 50 o C in a heterogeneous incubation mixture containing a suspension of 50 mg of 60% deacetylated chitosan, 1 ml of enzyme preparation, and 5 ml of 50 mM Tris-HCl buffer (pH 8.5). The released acetic acid concentration was measured [27] . One activity unit (U) was defined as the amount of the enzyme required to release 1 µmol acetic acid per minute. All measurements were carried out in triplicate.
RESULTS
Chemical Synthesis of the ClCDA Gene
The length of the original CDA sequence of C. lindemuthianum is 747 bp, and contains a putative signal peptide (27 amino acids) at its N terminus. The optimized ClCDA (666 bp), The underlined parts of p-clcd-1 and p-clcd-22 were attached with part of the CpoI and NotI restriction sites, respectively.
